期刊文献+

不同药物胸腔灌注治疗恶性胸腔积液的临床体会 被引量:16

Clinical experience of different drugs intrapleural injection in the treatment of malignant pleural effusion
下载PDF
导出
摘要 目的比较单独应用顺铂或香菇多糖以及两者联合进行胸腔灌注治疗恶性胸腔积液的疗效及不良反应。方法采用中心静脉导管留置引流术,对120例恶性胸腔积液患者随机分别采用单纯顺铂、单纯香菇多糖或香菇多糖联合顺铂胸腔灌注治疗,治疗4周后按WHO标准评价近期疗效和毒副反应。结果联合组有效率优于单纯顺铂或单纯香菇多糖组;联合组患者的不良反应低于单纯顺铂组,但高于单纯香菇多糖组。结论香菇多糖联合顺铂胸腔灌注是治疗恶性胸腔积液的有效手段。 Objective To compare the curative effect and adverse reactions between cisplatin alone and len tinan and combined with intrapleural injection in the treatment of malignant pleural effusion. Methods Using the central venous catheter for drainage of pleural cavity, 120 cases of malignant pleura effusion were randomly intra pleurally injected with cisplatin alone, or lentinan alone or lentinan combined with cisplatin, and the efficacy and tox icity were evaluated 4 weeks after the treatment according to WHO criteria. Results The efficacy was better in the combination group than the cisplatin or lentinan group. The incidence of adverse reactions was lower in the combina tion group than in the cisplatin group, but higher than that in the lentinan group. Conclusion Intrapleural infusion of lentinan combined with cisplatin is an effective method in the treatment of malignant pleural effusion.
出处 《临床肺科杂志》 2014年第3期497-498,共2页 Journal of Clinical Pulmonary Medicine
关键词 香菇多糖 顺铂 胸腔灌注 恶性胸腔积液 lentinan cisplatin intrapleural injection malignant pleural effusion
  • 相关文献

参考文献7

  • 1张弘,蔡柏蔷.恶性胸腔积液[A].//蔡柏蔷,李龙芸.协和呼吸病学[M].北京:中国协和医科大学出版社,2005:1360.
  • 2Guo Haisheng, Wan Yunyan, Tian Guangyan, et al. EGFR muta- tions predict a favorable outcome for malignant pleur'al effusion of lung adenocarcinoma with Tarceva therapy[ J]. Oncol Rep. ,2012, 27, (3) :880 -90.
  • 3Tohda Y, I wanaga T, 11 akada M, et al. lntrapleural administration of cisplatin and etoposide to treat malignant pleural efusions in pa- tients with non-small cell lung cancer [ J]. Chemotherapy, 1999, 45,197 - 204.
  • 4赵秋良,张维维,徐健,唐敏,费玲,何灿明,虞嘉康.甘露聚糖肽联合顺铂治疗恶性胸腔积液的临床疗效[J].临床肺科杂志,2012,17(2):313-315. 被引量:13
  • 5Wang X, Zhang L. Physieoehemieal properties and antitumor activi- ties for sultb.ted derivatives of lentinan [ J ]. Carbo - hydr Res, 2009,344(16) :2209 -2216.
  • 6McCORMACK E,SKAVLAND J,MUJIC M,et al. Lentinan:hema- topoietic,immunological,and eli cacy studies in a syngeneic model of acute myeloid leaemia [J].Nutr Cancer, 2010,62 ( 5 ) : 574 - 583.
  • 7Yoshino S, Watanabe S, hnano M, el aI. Improvement of QOI, and pmgnnsis by treatment of superfine dispersed lentinan in patients with advanced gaslric caneer[J]. [tepatogastroenterolngy,2010,57 (97) :172 - 177.

二级参考文献3

  • 1Tanaka A, Sato T, Adhesion thrapy for malignant pleural effusion (intrapleural aministration of 0k2432 with minoncycline ) [ J ]. Ni- hon kokyuki Gakkai Zasshi, 1999, 37 (7) :531 -537.
  • 2Yamagiwa S, Ichida T, Sato K, et al. Lipo some encapsulated 0k2432 specifically and sustainedly induces hepatic natural killer ceils an intermediate T cell receptor ceils [ J ]. J Gastroenterol Hepa- tol,2000,15(5) :542 -549.
  • 3郝春成(综述),葛晓峰(审校).恶性胸腔积液的治疗进展[J].实用肿瘤学杂志,2009,23(2):192-196. 被引量:11

共引文献16

同被引文献121

引证文献16

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部